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1. Introduction
Epidemiological data indicate that a number of autoimmune 
diseases are more prevalent in females than in males. These in-
clude systemic lupus erythematosus (9 to 13:1), Sjogren’s syn-
drome (9:1), myasthenia gravis (2 to 14:1), scleroderma (3 to 
4:1), Hashimoto’s thyroiditis (3:1), multiple sclerosis (MS) (2 to 
3:1), and rheumatoid arthritis (2:1) (Ahmed et al., 1999; Bee-
son, 1994; Lockshin, 2001;  Whitacre, 2001). MS is a chronic 
demyelinating disease of the central nervous system (CNS). 
The disease severity in female patients is reduced during preg-
nancy, but the symptoms of MS return to their pre-pregnant 
state within six months post-delivery (Confavreux et al., 1998). 
Such an alteration in the disease course is attributed to ele-
vated amounts of T helper (Th) 2 cytokines during pregnancy. 
In contrast, men are less likely to develop MS than women, but 
they tend to develop a more severe, chronic form of the disease 
(Compston et al., 1998) and the underlying mechanisms are 
unknown.
Three major myelin antigens (Ag), namely proteolipid pro-
tein (PLP), myelin basic protein (MBP) and myelin oligoden-
drocyte glycoprotein (MOG), have been identified as candidate 
autoantigens in MS pathogenesis. Healthy humans carry my-
elin-reactive cells in their naïve periphery, but CNS autoimmu-
nity does not occur spontaneously. How this tolerance is main-
tained is a fundamental question. It has been suggested that 
the environmental Ag that bear structural similarities to self-
Ag break self-tolerance by cross-reactivity. This is the basis for 
the molecular mimicry hypothesis, and several microbial mim-
ics have been shown to induce CNS inflammation through the 
generation of cross-reactive T cells in an adjuvant protocol of ex-
perimental autoimmune encephalomyelitis (EAE) (Sospedra and 
Martin, 2005).
EAE can be induced in mice with whole myelin proteins or 
their peptides, such as MBPAc 1–11, MOG 35–55 and PLP 139–
151, and the disease is primarily mediated by CD4 T cells. MBP 
Ac 1–11 induces the monophasic form of EAE in B10.PL or PL/J 
(IAu) mice; MOG 35–55 induces the chronic progressive form 
in C57BL/6 (IAb) mice; and PLP 139–151 induces relapsing–re-
mitting paralysis in SJL (IAs) mice (Miller and Karpus, 2007). 
These phenotypes resemble some of the clinical features of MS, 
making observations in mice relevant to humans. Gender bias 
in susceptibility to EAE exists for all of the above Ag, except for 
MOG 35–55-induced EAE in C57BL/6 mice (Okuda et al., 2002), 
suggesting that gender differences vary depending on the type 
of Ag or genetic backgrounds.
Our studies involve PLP 139–151-induced EAE in SJL mice. 
While both male and female mice develop PLP-induced EAE 
with equal severity, relapses occur only with females, and the 
disease is restricted to the monophasic form in males (Bebo et 
al., 1996). We recently identified a mimicry epitope from Acan-
thamoeba castellanii (A. castellanii), called ACA 83–95, that in-
duces autoimmune encephalomyelitis by generating T cells that 
cross-react with PLP 139–151 (Massilamany et al., 2010). Using 
ACA 83–95 as a test antigen, we addressed the hypothesis that 
CNS autoimmunity induced by cross-reactive environmental Ag 
differs by gender. We provide evidence that in response to ACA 
83–95 both male and female SJL mice generate similar frequen-
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cies of PLP 139–151-reactive T cells, but encephalitogenicity dif-
fers by gender during the effector phase of disease induction.
2. Materials and methods
2.1. Mice
Five-to-six-week-old male and female SJL/J (H-2s) mice were 
obtained from the Jackson Laboratory (Bar Harbor, ME). The 
mice were maintained in accordance with the animal protocol 
guidelines of the University of Nebraska-Lincoln, Lincoln, NE.
2.2. Peptide synthesis and immunization procedures
PLP 139–151 (HSLGKWLGHPDKF), ACA 83–95 (YFLLKWL-
GHPNVS) and neuraminidase (NASE) 101–120 (EALVRQGLAK-
VAYVYKPNNT) were synthesized on 9-fluorenylmethyloxycar-
bonyl chemistry (Neopeptide, Cambridge, MA). All peptides 
were HPLC-purified (>  90%), identity was confirmed by mass 
spectroscopy, and the peptides were dissolved in 1  ×  PBS. To 
measure recall responses, peptides were emulsified in complete 
Freund’s adjuvant (CFA) and administered s.c. in multiple sites 
in the flank and sternum (100  μg per mouse). For disease in-
duction, Mycobacterium tuberculosis H37RA extract (Difco Labo-
ratories, Detroit, MI) was added as an additional component to 
a final concentration of 5 mg/ml. Pertussis toxin (PT) (List Bi-
ological Laboratories, Campbell, CA) was administered (100 ng 
per mouse) i.p. on day 0 and day 2 postimmunization.
2.3. Induction of adoptive transfer EAE (AT-EAE)
Groups of mice were immunized with 100 μg of either PLP 
139–151 or ACA 83–95 per mouse. After ten days, mice were 
killed and the inguinal, axillary, cervical, maxillary, and man-
dibular draining lymph nodes (LN) were harvested, and sin-
gle cell suspensions were prepared after lysing the erythrocytes 
with 1 × ammonium chloride potassium buffer (Lonza, Walkers-
ville, MD). Lymph node cells (LNC) were stimulated with pep-
tides (20  μg/ml) and rested for 14  days in medium containing 
interleukin (IL)-2. The cells were restimulated with PLP 139–
151 or ACA 83–95 (20 μg/ml) in the presence of syngeneic an-
tigen-presenting cells for two days, and the cultures were main-
tained in IL-2 medium. Viable lymphoblasts were harvested on 
day 4 postimulation by Ficoll-hypaque density gradient centrif-
ugation, and groups of naive male and female SJL mice were in-
jected i.p. with 10 × 106 cells per mouse (Whitham et al., 1991). 
PT (100 ng) was administered i.p. on days 0 and 2 posttransfer 
and the disease was scored.
Figure 1. Gender differences in the susceptibility to autoimmune encephalomyelitis induced with ACA 83–95. (a) EAE induction by active immunization. 
Groups of male and female SJL mice were immunized with PLP 139–151 or ACA 83–95 in CFA s.c., and PT was administered i.p. on day 0 and day 2 postim-
munization. The mice were monitored for signs of EAE and scored (i), and the cumulative scores obtained by adding the scores from each mouse in a group 
were compared between different groups (ii). Data represent mean ± SEM values of four individual experiments and in one experiment, animals were not 
scored from days 24 to 26. (b) EAE induction by adoptive transfer. Short-term T cell lines were derived from male and female SJL mice immunized with PLP 
139–151 or ACA 83–95 as described in methods. Viable lymphoblasts were harvested on day 4 and administered into naïve recipients i.p., and PT was given 
i.p. on day 0 and day 2 posttransfer. The mice were monitored for clinical signs of EAE and scored (PLP groups, n = 3 to 6; ACA groups, n = 5–6).
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2.4. Clinical scoring and histopathology
Following EAE induction, the mice were monitored for clin-
ical signs of disease and scored as described previously (Tuohy 
et al., 1989): 0 – healthy; 1 – limp tail or hind limb weakness but 
not both; 2 – limp tail and hind limb weakness; 3 – partial pa-
ralysis of hind limbs; 4 – complete paralysis of hind limbs; 5 – 
moribund or dead. The neurological scores obtained from each 
mouse in a group were added to obtain cumulative scores and 
compared between groups. Animals were euthanized upon ter-
mination and brain and spinal cords were collected in 10% phos-
phate buffered formalin and analyzed for histological evidence 
of the disease (Massilamany et al., 2010; Sobel et al., 1990). Af-
ter fixation, brain sections were made through the cerebrum, 
hippocampus, cerebellum, and brainstem. In the spinal cord, 
the cervical, thoracic, lumbar, and sacral regions were each made 
into three sections, and the tissues were stained by Hematox-
ylin and Eosin staining. Tissues were blinded to treatment and 
scored for lesion type and severity and counts were added to-
gether. Total scores were obtained by adding counts of inflam-
matory foci in both meninges and parenchyma. Inflammation 
was primarily classified as lymphocytic, suppurative, or mixed 
(Massilamany et al., 2010).
2.5. T cell proliferation assay
Ten days after immunization with the indicated peptides, 
mice were killed and the draining LN were harvested to obtain 
single cell suspensions. LNC were stimulated with PLP 139–
151, ACA 83–95, and NASE 101–120 (control) at a cell density 
of 5 × 106 cells/ml for two days in RPMI medium supplemented 
with 10% fetal calf serum, 1 mM sodium pyruvate, 4 mM L-glu-
tamine, 1 × each of non-essential amino acids and vitamin mix-
ture, and 100  U/ml penicillin–streptomycin (Lonza). Cultures 
were then pulsed with 1 μCi of tritiated 3[H] thymidine per well; 
16 h later, proliferative responses were measured as counts per 
minute (cpm) using the Wallac liquid scintillation counter (Per-
kin Elmer, Waltham, MA).
2.6. IAs tetramer staining
To determine the frequency of antigen-specific T cells, IAs/
PLP 139–151, ACA 83–95 and Theiler’s murine encephalomy-
elitis virus (TMEV) 70–86 tetramers were created as described 
(Massilamany et al., 2010). LNC obtained from the mice immu-
nized with PLP 139–151 or ACA 83–95 were stimulated with 
the corresponding peptides (20 μg/ml) for six days. Viable lym-
phoblasts were incubated with phycoerythrin (PE)-conjugated 
IAs tetramers (30 μg/ml) at room temperature for 3 h (Massila-
many et al., 2010; Reddy et al., 2003). After washing twice, cells 
were stained with anti-CD4 and 7-amino-actinomycin-D (7-
AAD) (Invitrogen, Eugene, OR) and acquired by flow cytometer 
(FACS Scan, BD Pharmingen, San Diego, CA). The frequency of 
tetramer+ (tet+) cells was then enumerated using Flow Jo soft-
ware (Tree Star, Ashland, OR) in a live (7-AAD−) CD4+ popula-
tion. To determine the Ag specificity of cross-reactive T cell re-
sponses induced with PLP 139–151 and ACA 83–95, four-color 
flow cytometric analysis was performed to include allophycocy-
anin (APC)-conjugated PLP 139–151- and ACA 83–95-PE tetra-
mers, anti-CD4, and 7-AAD. Cells were acquired by FACS Calibur 
(BD Pharmingen) and the frequency of tet+ cells was analyzed 
using Flow Jo software in the live (7-AAD−) CD4+ subset.
2.7. Cytokine measurement
We measured the synthesis of IL-2, interferon (IFN)-γ, IL-
4, IL-10, IL-17A, IL-17F, IL-22, tumor necrosis factor (TNF)-α, 
and granulocyte-macrophage colony-stimulating factor (GM-
CSF) by intracellular staining and/or cytokine ELISA. The fre-
quency of cytokine-secreting cells was determined in LNC ob-
tained from mice immunized with PLP 139–151 or ACA 83–95 
by flow cytometry (Massilamany et al., 2010;  Reddy et al., 
2004). Briefly, LNC were stimulated with peptides (20  μg/ml) 
for two days and the cultures were maintained in IL-2 medium. 


























Table 1. Clinical and histologic EAE in SJL male and female mice induced with PLP 139–151 and ACA 83–95.  (Numbers are mean ± SEM.)
Treatment                                  Clinical disease                                     No. of inflammatory foci 
                                          Incidence (%)   Mean day of onset*    Mean maximum score*                                     Meninges                       Parenchyma                    Total 
PLP 139–151      
    Males 29/30 (96.6)            12.34 ± 0.29 2.86 ± 0.18 48.03 ± 9.54 23.50 ± 6.44 71.23 ± 15.56
    Females 27/29 (93.1)            13.59 ± 0.61 3.19 ± 0.15 75.62 ± 9.88 34.83 ± 6.71 112.69 ± 16.07
    p values    2.89E−10 2.59E−05 4.84E−11
ACA 83–95      
    Males   34/40 (85.0)            11.56 ± 0.28 1.91 ± 0.13 8.63 ± 2.92 5.83 ± 2.32 14.38 ± 5.17
    Female 32/38 (84.2)            11.56 ± 0.62 2.59 ± 0.18 19.71 ± 4.94 12.37 ± 4.34 32.37 ± 8.92
    p values    2.06E−06 2.34E−04 4.54E−07
Scoring scale: 0, healthy; 1, limp tail or hind limb weakness but not both; 2, limp tail and hind limb weakness; 3, partial paralysis of hind limbs; 4, complete 
paralysis of hind limbs; 5, moribund or dead.
* Represents only mice that showed clinical disease.
Figure 2. ACA 83–95 induces PLP 139–151-reactive T cell responses equally 
in both male and female SJL mice. Groups of male and female SJL mice were 
immunized with PLP 139–151 or ACA 83–95 in CFA. Ten days later, the 
mice were killed, LN were harvested, and single cell suspensions were pre-
pared. LNC were stimulated with PLP 139–151, ACA 83–95, and NASE 101–
120 (control) for two days. Cells were then pulsed with tritiated 3[H] thymi-
dine for 16 h, the incorporation of which was measured as cpm. Mean ± SEM 
values for a group of mice are shown.
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for approximately 5  h with phorbol 12-myristate 13-acetate 
(PMA) (10  ng/ml) and ionomycin (150  ng/ml) (Sigma-Aldrich, 
St. Louis, MO) in the presence of monensin 2 mM (GolgiStop, 
BD Pharmingen). After staining with anti-CD4 and 7-AAD, cells 
were fixed, permeabilized and stained with cytokine antibodies 
or isotype controls (eBioscience, San Diego, CA). The frequency 
of cytokine-secreting cells was then determined in the live (7-
AAD−) CD4+ subset by flow cytometry (FACS Scan, BD Pharmin-
gen). To estimate the frequency of cytokine-producing PLP 
139–151-specific cells, lymphoblasts were first stained with PLP 
139–151 tetramers, followed by staining with anti-CD4, 7-AAD 
and cytokine antibodies, and the cells were acquired by flow cy-
tometry. Frequencies of cytokine-producing PLP 139–151 tet+ 
cells were then determined in the live (7-AAD−) CD4 popula-
tion using Flow Jo software. Culture supernatants harvested on 
day 2 poststimulation with peptides were analyzed by cytokine 
ELISA. The clones of antibodies used for cytokine measurement 
were as previously published (Massilamany et al., 2010).
2.8. Analysis of T cell receptor (TCR) vβ usage
LNC obtained from the mice immunized with PLP 139–151 or 
ACA 83–95 were stimulated with peptides for two days (20 μg/
ml) and maintained in medium containing IL-2 for five days. 
Cells were stained with a panel of anti-mouse TCR vβ antibodies: 
vβ 2, 3, 4, 5.1, 5.2, 6, 7, 8.1, 8.2, 8.3, 9, 10b, 11, 12, 13, 14 and 
17a (BD Pharmingen), anti-CD4, and 7-AAD. After washing, cells 
were acquired by flow cytometer and the percentages of TCR vβ+ 
cells were enumerated in the live (7-AAD−) CD4 population. To 
determine the frequency of TCR vβ+ PLP 139–151-specific cells, 
Figure 3. Antigen-specificity of cross-reactive T cells induced with PLP 139–151 or ACA 83–95. (a) Antigen specificity. Male and female SJL mice were immu-
nized with PLP 139–151 or ACA 83–95 in CFA. After ten days, mice were killed and LNC were prepared from the draining LN and stimulated with the indi-
cated peptides. Viable lymphoblasts were harvested on day 6 poststimulation and stained with IAs/tetramers, namely PLP 139–151, ACA 83–95, and TMEV 
70–86 (control), followed by staining with anti-CD4 and 7-AAD. Cells were acquired by flow cytometry and the percentages of tet+ cells were analyzed in the 
live (7-AAD−) CD4 subset. (b) Detection of cross-reactive T cells by double tetramer staining. Cells from the above cultures were stained with PLP 139–151-
APC and ACA 83–95-PE tetramers, followed by staining with anti-CD4 and 7-AAD. After acquiring the cells by flow cytometry, double tet+ cells were analyzed 
in the live (7-AAD−) CD4 subset.
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Figure 4. ACA 83–95-induced PLP 139–151-reactive T cells produce similar patterns of cytokines in both male and female SJL mice. (a) Detection of cyto-
kine-secreting cells by intracellular staining. Groups of male and female SJL mice were immunized with PLP 139–151 or ACA 83–95; the mice were killed ten 
days later and LN were harvested to prepare single cell suspensions. LNC were stimulated with peptides for two days and the cultures were maintained in IL-2 
medium. Viable lymphoblasts were harvested on day 5 poststimulation and stimulated with PMA and ionomycin for approximately 5 h, followed by stain-
ing with anti-CD4 and 7-AAD. After fixation and permeabilization, the cells were incubated with cytokine antibodies and the frequency of cytokine+ cells was 
enumerated by flow cytometry in the live (7-AAD−) CD4+ T cells. Mean ± SEM values are shown (n = 4). (b) Cytokine ELISA. Cytokines in the supernatants 
harvested on day 2 from the above cultures were determined by ELISA. (c) Enumeration of the frequency of cytokine-secreting PLP 139–151 tet+ cells. Via-
ble lymphoblasts were harvested from peptide-stimulated cultures and the cells were first stained with PLP 139–151-APC tetramers followed by staining with 
anti-CD4, 7-AAD and cytokine antibodies. After acquiring the cells by flow cytometry, percentages of cytokine-secreting PLP 139–151 tet+ cells were deter-
mined in the live CD4 subset. A representative from three individual experiments involving three mice in each group is shown.
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Figure 5. TCR vβ usage in PLP 139–151-reactive 
T cells generated in response to ACA 83–95 dif-
fers from PLP 139–151. (a) TCR vβ usage in CD4 T 
cells. Groups of male and female SJL mice were im-
munized with PLP 139–151 or ACA 83–95; ten days 
later, mice were killed and LN were harvested. LNC 
were stimulated with peptides for two days and 
maintained in IL-2 medium. Cells harvested on day 
7 poststimulation were stained with a panel of anti-
TCR vβ and anti-CD4 and 7-AAD. After acquiring the 
cells by flow cytometer, percentages of TCR vβ+CD4+ 
cells were determined in the live (7-AAD−) popula-
tion. (b) TCR vβ usage in PLP 139–151 tet+ cells. 
LNC cultures were prepared from the mice immu-
nized with PLP 139–151 or ACA 83–95 as above. Vi-
able lymphoblasts were harvested on day 7 poststim-
ulation and stained with PLP 139–151 tetramers, 
followed by anti-CD4, anti-TCR vβ and 7-AAD. Cells 
were acquired by flow cytometer and the percentages 
of TCR vβ+PLP 139–151 tet+ cells were determined 
in the live (7-AAD−) CD4 subset.
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lymphocytes were stained first with PLP 139–151 tetramers, fol-
lowed by anti-CD4 and 7-AAD (Greve et al., 2004). After the cells 
were acquired by flow cytometry, the frequency of PLP 139–151 
tet+ cells was enumerated in relation to TCR vβ expression in the 
live (7-AAD−) CD4 subset using Flow Jo software.
2.9. Statistics
The Wilcoxon rank sum test was used to compare differences 
in the severity of clinical and histological EAE induced with PLP 
139–151 or ACA 83–95. Time-course analysis of clinical EAE in-
duced by active immunization involved the use of median values 
of clinical scores taken within individual animals for two time 
periods, days 9–15 and days 1–30 postimmunization, and the 
data were analyzed using Matlab software. Cumulative scores 
for each animal within a group were obtained by adding the 
scores of all the days and comparisons were then made between 
groups. Gender differences in T cell proliferation, cytokine-se-
cretion, and TCR vβ usage were analyzed by Student’s t. p ≤ 0.05 
values were used to determine significance.
3. Results
3.1. ACA 83–95 induces autoimmune encephalomyelitis in 
both male and female SJL mice by active immunization, but 
the effector cells generated in males are less pathogenic than 
those generated in females
We used active immunization and AT-EAE protocols to deter-
mine gender differences in the susceptibility to autoimmune en-
cephalomyelitis induced with ACA 83–95. These protocols in-
volved PLP 139–151-induced EAE as a positive control system 
to which the disease phenotype of ACA 83–95 was compared. As 
shown in Figure 1a, both PLP 139–151 and ACA 83–95 induced 
clinical signs of EAE in male and female SJL mice. Although clini-
cal signs induced by both peptides were identical, the disease on-
set occurred relatively earlier with ACA 83–95 (males and females: 
11.56) than with PLP 139–151 (males, 12.34; females, 13.59) (Ta-
ble 1). Time-course comparison of clinical EAE revealed that the 
EAE severity induced with ACA 83–95 was significantly lower 
than that induced with PLP 139–151 in both males (mean maxi-
mum scores: 1.91 vs. 2.86; p = 2.94E−05) and females (mean max-
imum scores: 2.59 vs. 3.19; p = 3.49E−05) ( Table 1). These dif-
ferences were also confirmed by comparing the cumulative scores 
between groups [ Figure 1a (ii)]. EAE severity induced with ACA 
83–95 was significantly greater in female mice during peaking of 
disease (9–15 days postimmunization) than in males (p = 0.022) 
( Figure  1a). Histologically, inflammatory infiltrates comprising 
predominantly mononuclear cells were also significantly higher in 
the brains and spinal cords of females than in males, regardless of 
immunogens used ( Table 1).
We next studied gender-biased differences in the adoptive 
transfer system by administering ACA 83–95-stimulated cells into 
naïve recipients and comparing the disease severity with mice in 
which EAE was induced with PLP 139–151-reactive cells. This was 
to better discern gender-disparity in T cell functions at the level 
of the effector phase. Figure 1b (i) shows that PLP 139–151-reac-
tive cells from males and females induced EAE with a comparable 
severity when cells were transferred into their corresponding gen-
ders and also into opposite sexes in criss-cross experiments, with 
one exception. That is, PLP-reactive T cells generated in males in-
duced relatively mild disease in females (mean maximum scores: 4 
vs. 5), and the mean day of disease-onset was delayed (male cells 
to males: day 9.33; male cells to females: day 30). One of the four 
female mice (25%) that received male cells showed a mild relapse 
(score 0 to 1) during days 55 to 58 posttransfer. The disease phe-
notype produced with ACA 83–95-reactive T cells, in contrast to 
PLP 139–151-reactive cells, differed in several aspects [Figure 1b 
(ii)]. (a) Cells from females induced EAE in both genders with a 
comparable severity (mean maximum scores: males, 3.5; females, 
4.0), but the mean day of disease onset was delayed in male re-
cipients (day 17.25) compared to female recipients (day 9.83). Re-
lapses occurred in 83% (5/6) of females that received cells from 
females. Likewise 40% (2/5) of males that received female cells 
also showed relapses. Among these, one animal showed relapses 
on two occasions, days 29–33 and 57–59 and both from scores 0 
to 1. Another animal showed a relapse with a score from 1 to 2 
during days 35–38. (b) Cells from males could induce disease in 
only 40% (2/5) of male recipients, the onset of which occurred on 
day 18.5 posttransfer, and one of them showed relapses; however, 
these cells failed to induce EAE in female recipients. Together the 
data suggest both male and female SJL mice are equally suscep-
tible to EAE induced with ACA 83–95 by active immunization, 
but the effector cells generated in males are less encephalitogenic 
than those generated in their female counterparts.
3.2. Male and female SJL mice respond equally to ACA 83–95
Groups of male and female SJL mice were immunized with 
ACA 83–95 or PLP 139–151, and ten days later, recall responses 
were measured based on tritiated 3[H] thymidine incorporation 
using NASE 101–120 as a negative control (Figure 2). ACA 83–95 
and PLP 139–151 induced T cell responses of a similar magnitude 
in both males and females in a dose-dependent manner, and a pro-
portion of this response was also attributed to the generation of 
T cells that cross-react with unimmunizing peptides. That is, the 
mice immunized with PLP 139–151 showed proliferative response 
to ACA 83–95, and vice versa, and the T cell responses were spe-
cific, since there was no response to NASE 101–120 (Figure 2).
3.3. ACA 83–95 induces similar frequencies of cross-reactive 
T cells in both male and female SJL mice
We determined antigen specificity and the precursor frequency 
of cross-reactive T cells induced with PLP 139–151 and ACA 83–
95 by flow cytometry using IAs/tetramers for PLP 139–151 and 
ACA 83–95 (Figure 3). LNC from mice immunized with ACA 83–
95 and PLP 139–151 were restimulated with corresponding pep-
tides and the cultures were maintained in IL-2 medium. Lympho-
blasts harvested on day 6 poststimulation were used for tetramer 
staining. In all of the staining reactions, TMEV 70–86 tetramers 
were used as negative controls, for which there was negligible 
binding in cultures stimulated with PLP 139–151 or ACA 83–95 
(Figure 3a). Tetramer analysis indicated that in mice immunized 
with PLP 139–151, PLP-reactive T cells expanded with compara-
ble proportions in both males (1.87%) and females (2.21%), and 
a subset of CD4 T cells also stained with ACA 83–95 tetramers 
expanded proportionally (males, 1.09%; females, 1.11%) (Fig-
ure  3a). In a similar analysis with ACA 83–95-immunized mice, 
it was found that males tended to respond relatively better to 
ACA 83–95 than females, and the percentages of ACA tet+ cells in 
male and female mice were estimated to be 9.28% and 6.32%, re-
spectively. Importantly, CD4 T cells from ACA 83–95-immunized 
mice also bind to PLP 139–151 tetramers, and the frequency of 
PLP tet+ cells tended to be higher in males (1.90%) than females 
(1.45%) (Figure  3a). We further verified the precursor frequen-
cies of cross-reactive T cells by double tetramer staining using PLP 
139–151 and ACA 83–95 tetramers (Figure  3b). First, we com-
pared the frequencies of total PLP 139–151-specific T cells gen-
erated in response to PLP 139–151 and ACA 83–95 by combining 
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the percentages of CD4 T cells that bind to PLP 139–151 tetra-
mers alone (upper left quadrant, Figure 3b) and those that bind to 
both PLP 139–151 and ACA 83–95 tetramers (upper right quad-
rant, Figure 3b). The mice immunized with PLP 139–151 showed 
two-fold increase in the proportion of PLP-reactive T cells (males, 
2.54%; females, 2.72%) over those immunized with ACA 83–95 
(males, 1.42%; females, 1.16%). Second, we estimated the fre-
quency of cross-reactive T cells that bind to both PLP 139–151 
and ACA 83–95 tetramers; the frequency was higher in mice im-
munized with ACA 83–95 (males, 0.83%; females, 0.60%) than in 
PLP 139–151-immunized mice (males, 0.33%; females, 0.45%) 
(Figure  3b). The tetramer analysis thus enabled us to conclude 
that ACA 83–95 is relatively more immunogenic in males than in 
females, which might have allowed the males to generate a mar-
ginally greater number of cross-reactive T cells than females.
3.4. Cytokine production in ACA 83–95-induced PLP 
139–151-reactive T cells does not differ by gender
We measured cytokines as readouts to determine the patho-
genicity of effector cells induced with PLP 139–151 and ACA 
83–95 (Figure 4). Cytokine secretion was measured in LNC cul-
tures obtained from mice immunized with the correspond-
ing peptides by intracellular staining and cytokine ELISA us-
ing a panel of Th1 (IL-2 and IFN-γ), Th2 (IL-4 and IL-10), Th17 
(IL-17A, IL-17F, and IL-22) and other inflammatory cytokines, 
namely, TNF-α and GM-CSF. As shown in Figure 4a, CD4 T cells 
capable of secreting both Th1 and Th17 cytokines were domi-
nant in cultures stimulated with ACA 83–95 or PLP 139–151, 
but there were no significant gender differences in the secretion 
of any of the cytokines tested. Similar patterns were also noted 
when cytokines were analyzed by ELISA (Figure 4b). Gender dif-
ferences in the ability to secrete IFN-γ and IL-17 were further 
verified at a single cell level in PLP-specific T cell populations by 
using PLP 139–151 tetramers. We calculated the percentages of 
cytokine-producing PLP tet+ cells using the formula: frequen-
cies of cytokine+tet+ cells (upper right quadrant)/[frequencies of 
cytokine+tet+ cells (upper right quadrant) + frequencies of cyto-
kine−tet+ cells (upper left quadrant)] × 100 (Figure 4c). The tet-
ramer analysis indicated that the frequencies of PLP tet+ cells 
capable of producing IFN-γ did not differ between genders, re-
gardless of the immunogens used (PLP 139–151: males,13.02%; 
females, 12.31%; ACA 83–95: males, 13.38%; females, 14.05%) 
On the contrary, frequencies of IL-17-secreting PLP tet+ cells 
tended to be higher in males than females (PLP 139–151: males, 
13.85%; females, 8.55%; ACA 83–95: males, 10.61%; females, 
7.26%). Collectively, the data indicate that both male and female 
mice can generate pathogenic cross-reactive T cells in response 
to ACA 83–95, suggesting that these cells have a potential to in-
duce CNS inflammation regardless of their gender origin.
3.5. TCR vβ usage differs in PLP 139–151-reactive T cells in-
duced with ACA 83–95 and those induced with PLP 139–151
To determine whether effector cells induced with PLP 139–
151 and ACA 83–95 use similar or alternate TCR vβs, we analyzed 
their surface expression in LNC cultures derived from male and 
female mice immunized with PLP 139–151 or ACA 83–95. Lym-
phoblasts harvested on day 7 poststimulation were used for anal-
ysis by flow cytometry (Figure  5a). In cultures stimulated with 
PLP 139–151 or ACA 83–95, expression of TCR vβ2, vβ17a, vβ4, 
vβ14, vβ6 and vβ3 occurred predominantly but in a decreasing 
order and together represented 65% of the total CD4 cell popula-
tion (Figure 5a). TCR vβ2 was expressed significantly more in ACA 
83–95-stimulated cultures (males, p = 0.004; females, p = 0.0001) 
than in PLP 139–151-stimulated cultures, with a corresponding 
decrease in TCR vβ17a (males, p = 0.0006; females, p = 0.0002). 
Likewise, TCR vβ14 expression was also marginally more in ACA 
83–95-stimulated cells than in cells stimulated with PLP 139–151 
in males (p = 0.056). We verified these differences and confirmed 
antigen-specificity of cross-reactive cells by tetramer analysis. We 
calculated the percentages of TCR vβ-expressing PLP-specific cells 
using the following formula: frequencies of vβ+tet+ cells (upper 
right quadrant)/[frequencies of vβ+tet+ cells (upper right quad-
rant) + frequencies of Vβ−tet+ cells (upper left quadrant)] × 100 ( 
Figure 5b). PLP 139−151 tet+ cells generated with both PLP 139–
151 and ACA 83–95 immunizations contained T cells express-
ing all of the above TCR vβs, but tetramer analysis revealed a few 
differences ( Figure 5b and Table 2). (a) TCR vβ2 was expressed 
more in PLP tet+ cells generated by ACA 83–95 in both males 
(p = 0.058) and females (p = 0.026), but frequencies of PLP tet+ 
cells expressing TCR vβ17a did not differ. (b) While TCR vβ3 ex-
pression was insignificant in PLP tet+ cells, TCR vβ14+ PLP tet+ 
cells tended to be higher in cells stimulated with ACA 83–95 than 
PLP 139–151-stimulated cells within males (p = 0.067). (c) PLP 
tet+ cells from female mice immunized with PLP 139–151 showed 
a marginal increase in the expression of TCR vβ6 as compared 
with males (p = 0.06). Overall, the expression pattern of TCR vβ 
usage revealed no gender differences, but PLP–specific cells in-
duced with ACA 83–95 utilize different pattern of TCR vβs as op-
posed to those induced with PLP 139–151, raising the question 
whether such variations contribute to disease susceptibility.
4. Discussion
By using ACA 83–95, we investigated whether disparity in 
T cell reactivity to microbial mimics contributes to gender dif-
ferences in CNS autoimmunity in SJL mice. Our data revealed 
that ACA 83–95-induced EAE was less severe in males than in 
females clinically (Figure  1a) and histologically (Table  1). In 
AT-EAE, we noted that PLP-reactive T cells obtained from fe-
male mice induced EAE with equal severity in both genders, 
whereas cells from males induced relatively mild EAE in females, 
the onset of which was significantly prolonged [Figure  1b (i)]. 
These data are consistent with the findings of others (Bebo et 
al., 1996, 1998;  Voskuhl et al., 1996). In contrast, gender dis-
parity was more pronounced with the disease produced by ACA 
83–95-stimulated cells. First, cells from female mice induced 
EAE in both male and female recipients [Figure 1b (ii)]. Second, 
cells from males induced only mild EAE in male recipients, but 
they failed to induce disease in female recipients. These find-
ings indicate that sex of both the donor and the recipient are 
critical for EAE induction with cross-reactive microbial Ag. Al-
ternatively, the inherent ability of males to resist the develop-
ment of EAE could explain the occurrence of a mild form of the 
disease in them. But it is hard to explain why females receiving 














Table 2. Analysis of TCR vβ-expressing PLP 139–151 tetramer+ cells.
TCR vβ                                  Immunized groupsa
  PLP 139–151             ACA 83–95
                           Male                 Female                       Male                 Female
vβ2 11.78 ± 3.76b 10.61 ± 2.98c 17.33 ± 1.63b 18.06 ± 2.27c
vβ3 2.38 ± 0.26 2.18 ± 0.74 10.02 ± 5.42 4.32 ± 1.35
vβ4 13.25 ± 1.44 11.43 ± 0.86 10.76 ± 4.12 15.66 ± 2.28
vβ6 3.90 ± 0.15d 4.93 ± 0.37d 6.06 ± 2.58 5.04 ± 0.61
vβ14 3.42 ± 0.35e 4.22 ± 0.16 5.13 ± 0.40e 3.93 ± 0.78
vβ17a 11.51 ± 1.24 11.14 ± 1.35 9.52 ± 3.00 8.00 ± 1.47
a. n = 3 each involving 2 to 3 mice per group.
b: p = 0.058 ; c: p = 0.026 ; d: p = 0.061 ; e: p = 0.067
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explain these differences, we investigated whether variations in 
the generation of the frequencies of antigen-specific cells, cyto-
kine secretion and TCR vβ usage in effector cells contribute to 
gender-disparity in EAE induced by ACA 83–95.
Induction of EAE by active immunization with myelin Ag 
first involves the generation of encephalitogenic T cells in the 
periphery followed by their migration into the CNS, which then 
mediates the inflammatory process. We verified that T cell re-
sponses of male and female SJL mice to both Ag were similar, 
including the magnitude, dose–response patterns, and cross-
reactivity (Figure  2). We confirmed these findings by tetramer 
analysis, which indicated that the frequency of total number of 
PLP tet+ cells generated in response to ACA 83–95-immuniza-
tion was two-fold lower than the frequency obtained with PLP 
139–151, regardless of gender (Figure 3b). This may be the rea-
son ACA 83–95-induced EAE was less severe than EAE induced 
by PLP 139–151. However, if gender bias exists at all, male mice 
immunized with ACA 83–95 have a tendency to generate more 
PLP 139–151-reactive T cells, as assessed by using PLP 139–
151 tetramers alone (Figure 3a) or a combination of both PLP 
139–151 and ACA 83–95 tetramers to determine double tet+ 
cells that represent cross-reactive T cell populations (Figure 3b). 
Therefore logically, ACA 83–95-induced PLP-reactive cells from 
males are expected to produce disease similar to that produced 
by female cells, but this was not the case. By analyzing cytokine 
production, we noted that Th1 and Th17 cytokine-producing 
cells were dominant in cultures stimulated with PLP 139–151 
or ACA 83–95, with a tendency for males to show a higher fre-
quency of IL-17-secreting cells than females (Figure  4). There-
fore, we think that variation in cytokine synthesis in male mice 
was also not a contributing factor in their development of a mild 
EAE phenotype. Taken together, our data suggest that both 
male and female mice respond equally to ACA 83–95 and gen-
erate similar frequencies of pathogenic cells, while the effector 
cells from males but not females lose their encephalitogenicity.
We then asked whether inherent variations in the enceph-
alitogenicity of PLP-reactive T cells induced with cognate (PLP 
139–151) and mimicry (ACA 83–95) epitopes in males and fe-
males were due to differences in TCR vβ usage. It has been 
shown that the pathogenic T cell repertoires induced by PLP 
139–151 are heterogenic in which TCR vβ2, 4, 6, 7, 14, and 17a 
are predominantly expressed (Kuchroo et al., 1992, 1994). Since 
the encephalitogenicity was weaker in effector cells induced by 
ACA 83–95 than in those induced by PLP 139–151, we asked 
whether ACA 83–95-induced effector cells use alternate TCRs 
such that the newly generated T cell clones are weakly enceph-
alitogenic. We addressed this possibility by using PLP 139–151 
tetramers. Although there were no gender differences, we noted 
that PLP 139–151 tet+ cells expressing TCR vβ2 were skewed 
in LNC cultures from mice immunized with ACA 83–95 with 
no significant variations in the other vβs (Table  2). Previously 
it was shown that spinal cord infiltrates from PLP 139–151-in-
duced EAE in SJL mice predominantly express TCR vβ2 and vβ 
17a (Bebo et al., 1996). The fact that ACA 83–95-induced EAE 
was less severe than EAE induced by PLP 139–151 in both gen-
ders in spite of significant increase in vβ2-expressing cells sug-
gests that they are not the major mediators of disease; rather, 
multiple T cell clones expressing heterogeneous TCR vβ chains 
are critical for disease induction by ACA 83–95.
Several factors contribute to gender bias in susceptibility to 
EAE. These include sex hormones, immune deviation, and func-
tional disparity in antigen-presenting cells (Bebo et al., 1996, 
2001; Offner, 2004; Voskuhl and Palaszynski, 2001). We previ-
ously demonstrated that regulatory T (Treg) cells mediate ge-
netic resistance to the development of EAE in B10.S (H-2s) mice 
(Reddy et al., 2005). We had proposed that males have a capac-
ity to generate potent autoreactive T cells but their expansion is 
kept in check by Treg cells. Once this check point is released, au-
toreactive T cells freely expand and induce CNS inflammation. 
Whether a similar mechanism contributes to the reduced patho-
genic potential of cross-reactive T cells induced by microbial 
products in males remains to be tested.
In summary, we show that both males and females gener-
ate similar frequencies of cross-reactive T cells for PLP, but their 
pathogenicity differs by gender during the effector phase of 
EAE induction. In contrast to PLP-reactive T cells obtained with 
PLP 139–151, encephalitogenicity of ACA 83–95-induced effec-
tor cells in males was weak, implying that environmental expo-
sure to mimicry peptides can lead to the generation of more po-
tent autoaggressive cells in females than in males. A. castellanii 
is a natural CNS pathogen of humans and the amoeba can in-
duce encephalitis in infected mice; both mouse and human iso-
lates of amoebae can induce histologically similar disease ( Culb-
ertson et al., 1959, Culbertson et al., 1958 and Marciano-Cabral 
and Cabral, 2003). This infection model can therefore be used to 
address gender-biased differences in the generation of autoreac-
tive T cells and their ability to induce CNS autoimmunity.
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